Cargando…
Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission
Gray zone lymphoma (GZL) is a rare type of B-cell lymphoma characterized by features of both diffuse large B-cell lymphoma and classical Hodgkin lymphoma (cHL). The prognosis of GZL is poorer than that of cHL and mediastinal large B-cell lymphoma. However, an optimal treatment strategy for relapsed/...
Autores principales: | Terao, Toshiki, Yuda, Junichiro, Yamauchi, Nobuhiko, Guo, Yong-Mei, Shimada, Kaoru, Sugano, Masato, Ishii, Genichiro, Minami, Yosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082227/ https://www.ncbi.nlm.nih.gov/pubmed/33936598 http://dx.doi.org/10.3892/mco.2021.2287 |
Ejemplares similares
-
Brentuximab Vedotin
Publicado: (2012) -
Brentuximab vedotin induced uveitis
por: Therssen, Stijn, et al.
Publicado: (2022) -
Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013) -
Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015) -
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
por: Forlenza, Christopher J., et al.
Publicado: (2023)